QuidelOrtho (QDEL) Gains from Investment Securities (2021 - 2026)

QuidelOrtho has disclosed Gains from Investment Securities across 6 years of filings, most recently posting $1.6 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $12.6 million (up 231.58% YoY), and the FY2025 annual result was $11.0 million, up 14.58% from the prior year.
• Gains from Investment Securities came in at $1.6 million for Q1 2026 at QuidelOrtho, down from $6.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $13.5 million in Q4 2023 to a low of -$27.4 million in Q1 2023.
• The 5-year median for Gains from Investment Securities is $2.8 million (2023), against an average of $1.1 million.
• Across the five-year window, Gains from Investment Securities slumped 93.33% in 2024 and surged 566.67% in 2025, its largest moves.
• QuidelOrtho's Gains from Investment Securities stood at $6.8 million in 2022, then surged by 98.53% to $13.5 million in 2023, then plunged by 93.33% to $900000.0 in 2024, then soared by 566.67% to $6.0 million in 2025, then plunged by 73.33% to $1.6 million in 2026.
• The last three Gains from Investment Securities figures came in at $1.6 million (Q1 2026), $6.0 million (Q4 2025), and $900000.0 (Q3 2025), per Business Quant data.